Quantcast

Latest Diagnostic tests Stories

2011-07-06 15:20:03

When a person living in a malarial area gets a fever, health workers need to know the cause to make absolutely sure they give the right treatment. For many years in sub-Saharan Africa primary health workers have often assumed a fever is caused by malaria, and given antimalarial drugs. This approach means sometimes people receive the wrong treatment for their illness. It also wastes resources and, over time, can promote resistance to available drugs. A new Cochrane Systematic Review examines...

2011-06-29 06:00:00

NEW YORK and QUEBEC CITY, June 29, 2011 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc. (TSX: CUR), a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years. This collaboration aims to maximize the commercialization of Previstage(TM) GCC Colorectal Cancer Staging Test, and further...

2011-06-17 08:00:00

IRVINE, Calif., June 17, 2011 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today announced a strategic partnership with CompanDX of Nottingham UK. ResearchDx and CompanDX have forged a unique partnership to offer a full capability to discover and deliver novel molecular diagnostic tests for clients in the healthcare setting. CompanDX uses its unique "Distiller" platform to deliver small composite biomarker signatures from complex data of high dimensionality, which are...

2011-06-07 08:15:00

SAN DIEGO, June 7, 2011 /PRNewswire/ -- bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID®, and Breast Cancer Index(SM). Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago. On June 6, scientists from bioTheranostics and the Institut...

2011-06-07 07:00:00

UNION CITY, Calif., June 7, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company's Animal Health group has added two new rapid diagnostic tests, the VetScan Canine Parvovirus Rapid Test and the VetScan Giardia Rapid Test. The VetScan Canine Parvovirus Rapid Test was launched in March 2011 and the VetScan Giardia Rapid Test began selling in May 2011 and both rapid tests have been well...

2011-06-06 15:02:00

QUEBEC CITY, June 6, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter of fiscal 2011. The Company announced a net loss of $1,601,439 or $0.04 per share for the quarter ended April 30, 2011. These results reflect activities undertaken during this quarter and the Company's on-going commitment to develop...

2011-06-01 20:30:00

BEIJING, June 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ended March 31, 2011 ("FY2010") today. 4Q FY2010 Highlights For the Three Months Ended --------------------------...

2011-03-31 07:00:00

HAYWARD, Calif. and MUNICH, March 31, 2011 /PRNewswire/ -- Advanced Cell Diagnostics (ACD), a technological leader in molecular pathology, and Definiens, a leading provider for biomedical image and data analysis, announce today a strategic partnership to develop image analysis applications that will enable researchers to accurately quantify specific RNA molecules within individual cells in routine clinical specimen. The partnership will build on ACD's RNAscope platform and add new...

2011-03-11 05:00:00

QUEBEC CITY, March 11 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the first quarter of fiscal 2011. The Company announced a net loss of $1,608,543 or $0.04 per share for the quarter ended January 31, 2011. These results reflect activities undertaken during this quarter and the Company's on-going commitment to...

2011-02-24 05:00:00

MADISON, N.J., Feb. 24, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it has signed a definitive agreement to acquire Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific (NYSE: TMO) for $740 million in cash. Athena Diagnostics is the leading provider of advanced diagnostic tests used to rule...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related